Diminished T cell numbers in patients with chronic granulomatous disease

Clinical Immunology

Volumn 105, Issue 3, 2002, Pages 273-278

  Heltzer, Meredith ^a   Jawad, Abbas F ^b   Rae, Julie ^c   Curnutte, John T ^c   Sullivan, Kathleen E ^b  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chronic granulomatous disease; Immunodeficiency; T cells

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BONE MARROW TRANSPLANTATION; CELL KILLING; CELL MIGRATION; CHRONIC DISEASE; ENZYME ACTIVITY; FLOW CYTOMETRY; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; T LYMPHOCYTE ACTIVATION;

EID: 0036917792     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5291     Document Type: Article

References (32)

1. Segal, B. H., Leto, T. L., Gallin, J. I., et al., Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 79, 170-200, 2000.
2. Clark, R. A., Malech, H. L., Gallin, J. I., et al., Genetic variants of chronic granulomatous disease: Prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N. Engl. J. Med. 321, 647-652, 1989.
3. Royer-Pokora, B., Kunkel, L. M., Monaco, A. P., et al., Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location. Cold Spring Harbor Symp. Quant. Biol. 51, 177-183, 1986.
4. Williams, D. A., Tao, W., Yang, F., et al., Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96, 1646-1654, 2000.
5. Ambruso, D. R., Knall, C., Abell, A. N., et al., Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc. Natl. Acad. Sci. USA 97, 4654-4659, 2000.
6. Winkelstein, J. A., Marino, M. C., Johnston, R. B., et al., Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79, 155-169, 2000.
7. Vowells, S. J., Fleisher, T. A., Sekhsaria, S., et al., Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J. Pediatr. 125, 104-107, 1996.
8. Foster, C. B., Lehrnbecher, T., Mol, F., et al., Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Invest. 102, 2146-2155, 1998.
9. Liese, J., Kloos, S., Jendrossek, V., et al., Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J. Pediatr. 137, 687-693, 2000.
10. Maly, F. E., Cross, A. R., Jones, O. T., et al., The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig. J. Immunol. 140, 2334-2339, 1988.
11. Dusi, S., Nadalini, K. A., Donini, M., et al., Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. J. Immunol. 161, 4968-4974, 1998.
12. Meier, B., Cross, A. R., Hancock, J. T., et al., Identification of a superoxide-generating NADPH oxidase system in human fibroblasts. Biochem. J. 275, 241-245, 1991.
13. Suzuki, Y., and Ono, Y., Involvement of reactive oxygen species produced via NADPH oxidase in tyrosine phosphorylation in human B- and T-lineage lymphoid cells. Biochem. Biophys. Res. Commun. 255, 262-267, 1999.
14. Hildeman, D. A., Mitchell, T., Teague, T. K., et al., Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744, 1999.
15. Los, M., Droge, W., Stricker, K., et al., Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25, 159-165, 1995.
16. Lahdenpohja, N., Savinainen, K., and Hurme, M., Pre-exposure to oxidative stress decreases the nuclear factor-kappa B-dependent transcription in T lymphocytes. J. Immunol. 160, 1354-1358, 1998.
17. Hehner, S. P., Breitkreutz, R., Shubinsky, G., et al., Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol. 165, 4319-4328, 2000.
18. + (memory T) cells in patients with chronic granulomatous disease. J. Infect. Dis. 167, 983-985, 1993.
19. Jawad, A. F., McDonald-McGinn, D. M., Zackai, E., et al., Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J. Pediatr. 139, 715-723, 2001.
20. Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. The European Collaborative Study. Pediatr. Infect. Dis. J. 11, 1018-1026, 1992.
21. + T cells. Res. Commun. Mol. Pathol. Parmacol. 104, 205-218, 1999.
22. Kotmire, S., Gupta, I., Ganguly, N. K., et al., Study of T-lymphocyte subpopulation in HBsAg-positive pregnant women. Acta Virol. 37, 459-465, 1993.
23. Sehgal, V. N., Wagh, S. A., Bhattacharya, S. N., et al., Peripheral T lymphocytes and their subsets in cutaneous tuberculosis. Int. J. Dermatol. 31, 110-112, 1992.
24. Bava, A. J., Mistchenko, A. S., Palacios, M. F., et al., Lymphocyte subpopulations and cytokine production in paracoccidioidomycosis patients. Microbiol. Immunol. 35, 167-174, 1991.
25. van der Veen, R. C., Dietlin, T. A., Hofman, F. M., et al., Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: Decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J. Immunol. 164, 5177-5183, 2000.
26. Babior, B. M., Benna, J. E., Chanock, S. J., et al., The NADPH oxidase of leukocytes: The respiratory burst of oxidase. In "Oxidative Stress and the Molecular Biology of Antioxidant Defenses." Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997.
27. van Reyk, D. M., King, N. J., Dinauer, M. C., et al., The intracellular oxidation of 2′,7′-dichlorofluorescin in murine T lymphocytes. Free Radical Biol. Med. 30, 82-88, 2001.
28. Los, M., Schenk, H., Hexel, K., et al., IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14, 3731-3740, 1995.
29. 2+ influx in human neutrophil granulocytes. Alterations in chronic granulomatous disease. J. Biol. Chem. 272, 26471-26478, 1997.
30. Banfi, B., Schrenzel, J., Nusse, O., et al., A novel H(+) conductance in eosinophils: Unique characteristics and absence in chronic granulomatous disease. J. Exp. Med. 190, 183-194, 1999.
31. Weening, R. S., Kabel, P., Pijman, P., et al., Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J. Pediatr. 103, 127-130, 1983.
32. The International Chronic Granulomatous Disease Cooperative Study Group, A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med. 324, 509-516, 1991.